Form D · Other
TetraScience, Inc.
Boston, MA · CIK 0001855742
Offering snapshot reported Feb 27, 2026 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 27, 2026 | Initial | $14,999,985 | No comparison | 11 | SEC filing |
| Apr 15, 2021 | Initial | $50,999,950 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-574899
Source: Form D, filed Feb 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maurice Bedoni | Executive |
| Remy Evard | Director |
| Patrick Grady | Director, Executive |
| Christopher Lynch | Director |
| Chris Lynch | Director |
| James S. Orsillo | Director, Executive |
| Deven Parekh | Director |
| Salvatore Savo | Director, Executive |
| Michael Skok | Director |
| Siping Wang | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
68 Harrison Ave, Suite 605, Pmb 37361
Boston, MA, 02111
Boston, MA, 02111